Research
Energy balance
Rifampicin inhibits body weight gain in high-fat diet-fed mice.
Rifampicin may be considered as a potential treatment for obesity in high-fat diet contexts.
StrongSupportsmedium confidence
Oral administration of rifampicin effectively inhibits body weight gain in HFD-fed mice.
Why this rating
Based on the experimental results presented in the abstract.
Source
Rifampicin prevents diet-induced obesity through Sirt6-dependent lipolysis, adipocyte browning and lipogenesis inhibition
Yang Xu et al. · Biomedicine & Pharmacotherapy · 2025
DOI 10.1016/j.biopha.2025.118226
otherCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →